GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IR Biosciences Holdings Inc (GREY:IRBS) » Definitions » PEG Ratio

IR Biosciences Holdings (IR Biosciences Holdings) PEG Ratio : N/A (As of Jun. 16, 2024)


View and export this data going back to . Start your Free Trial

What is IR Biosciences Holdings PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, IR Biosciences Holdings's PE Ratio without NRI is 0.00. IR Biosciences Holdings's 5-Year EBITDA growth rate is 0.00%. Therefore, IR Biosciences Holdings's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for IR Biosciences Holdings's PEG Ratio or its related term are showing as below:



IRBS's PEG Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 1.565
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


IR Biosciences Holdings PEG Ratio Historical Data

The historical data trend for IR Biosciences Holdings's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IR Biosciences Holdings PEG Ratio Chart

IR Biosciences Holdings Annual Data
Trend Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

IR Biosciences Holdings Quarterly Data
Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of IR Biosciences Holdings's PEG Ratio

For the Biotechnology subindustry, IR Biosciences Holdings's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IR Biosciences Holdings's PEG Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IR Biosciences Holdings's PEG Ratio distribution charts can be found below:

* The bar in red indicates where IR Biosciences Holdings's PEG Ratio falls into.



IR Biosciences Holdings PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

IR Biosciences Holdings's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=/0.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


IR Biosciences Holdings  (GREY:IRBS) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


IR Biosciences Holdings PEG Ratio Related Terms

Thank you for viewing the detailed overview of IR Biosciences Holdings's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


IR Biosciences Holdings (IR Biosciences Holdings) Business Description

Traded in Other Exchanges
N/A
Address
8777 E. Via De Ventura, Suite 280, Scottsdale, AZ, USA, 85258
IR Biosciences Holdings Inc is a development-stage biotechnology company engaged in the research & development of potential drug candidate, Homspera and its derivatives, Radilex and Viprovex through its subsidiary, ImmuneRegen BioSciences, Inc. It is engaged in the research and development of therapies in the areas of pulmonary fibrosis, influenza infection, and radiation-induced Neutropenia.

IR Biosciences Holdings (IR Biosciences Holdings) Headlines

No Headlines